HIVBlogger

HIVBlogger

living positively

Menu Skip to content
  • Buy me a Coffee
  • New item

Day: April 28, 2024

2024-04-28 Michael McFarland Campbell

Back to Juluca – transplant-friendly meds

Michael McFarland Campbell

Michael McFarland Campbell

Michael McFarland Campbell is a neurodivergent liturgical writer, organist, and storyteller living with chronic illness and fierce compassion. Rooted in Benedictine spirituality, his work transforms everyday routines—dialysis, knitting, walking, pain management—into sacred reflections. Through humour, advocacy, and creative care, he uplifts the dignity of the misunderstood and inspires inclusive acts of hope, connection, and healing.

View Full Profile →

Let’s get talking about mental health

proud to wear the green ribbon - and a green ribbon below.

Social

  • View michaelmcfarlandcampbell’s profile on Facebook
  • View hivblogger’s profile on Twitter
  • View hivblogger’s profile on Instagram
  • View michaelmcfarlandcampbell’s profile on LinkedIn
  • View michaelmcfarlandcampbell’s profile on GitHub
  • View gyronny’s profile on WordPress.org
HIV Blood results
Dialysis blood results
April 2024
S M T W T F S
 123456
78910111213
14151617181920
21222324252627
282930  
« Mar   May »

Blog Stats

  • 95,043 hits

Enter your email address to follow this blog and receive notifications of new posts by email.

Join 718 other subscribers

  • Andrew McFarland Campbell's avatar Andrew McFarland Campbell
  • Michael McFarland Campbell's avatar Michael McFarland Campbell
  • hivblogger's avatar hivblogger
  • maddy2wright's avatar maddy2wright

Meta

  • Create account
  • Log in
  • Entries feed
  • Comments feed
  • WordPress.com
Website Powered by WordPress.com.
  • Subscribe Subscribed
    • HIVBlogger
      • Join 252 other subscribers
    • Already have a WordPress.com account? Log in now.
    • HIVBlogger
    • Subscribe Subscribed
    • Sign up
    • Log in
    • Report this content
    • View site in Reader
    • Manage subscriptions
    • Collapse this bar
Privacy & Cookies: This site uses cookies. By continuing to use this website, you agree to their use.
To find out more, including how to control cookies, see here: Our Cookie Policy